Kanya Rajangam Nkarta, Inc. (NKTX) insider trading activity

NKTX Quotes by TradingView

Kanya Rajangam is Chief Medical Officer of Nkarta, Inc.. Currently has a direct ownership of 12,800 shares of NKTX, which is worth approximately $57,855. The most recent transaction as insider was on Jan 14, 2022, when has been sold 12,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K
0% 3M change
0% 12M change
Total Value Held $57,855

Kanya Rajangam Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 14 2022
BUY
Grant, award, or other acquisition
-
12,800 Added 50.0%
12,800 Common Stock
Aug 05 2021
SELL
Open market or private sale
$372,800 $37.28 p/Share
10,000 Reduced 100.0%
0 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$4,100 $0.41 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

SNTI
Senti Biosciences, Inc. Healthcare
Chief Medical & Devt. Officer
TSBX
Turnstone Biologics Corp.
KR

Kanya Rajangam

Chief Medical Officer
South San Francisco, CA

Track Institutional and Insider Activities on NKTX

Follow Nkarta, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTX shares.

Notify only if

Insider Trading

Get notified when an Nkarta, Inc. insider buys or sells NKTX shares.

Notify only if

News

Receive news related to Nkarta, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NKTX